M eningococcal infection is reported
sporadically from all parts of India and epidemics occur at regular
intervals. In Delhi, it has been causing recurrent epidemics since 1966.
Till date, all outbreaks in Delhi have been caused by serotype A(1).
In 2005-2006, there was sudden increase in cases of
meningococcal infection in Delhi and an outbreak was declared. This study
describes the disease spectrum during this outbreak.
Methods
This is a descriptive retrospective study of children
admitted with meningococcal infection between April 2005 and December 2006
in a tertiary care Government hospital at Delhi. At admission, blood and
CSF (cerebrospinal fluid) were collected using aseptic precautions and
sent to the laboratory immediately for culture sensitivity and serological
testing. CSF cytology and Gram staining was also done. The case sheets of
all these children were subsequently retrieved and reviewed. Meningococcal
infection was classified according to standard case definitions given
below(1).
Probable meningococcal meningitis: A child with
sudden onset fever (axillary temperature >38ºC
or rectal temperature >38.5ºC) with neck stiffness (except in children
below one year) and turbid CSF, during ongoing epidemic or Gram stain
showing gram negative diplococci or petechial/purpural rash.
Confirmed meningococcal meningitis: A child who has
suspicion of probable meningococcal meningitis and in addition N.
meningitides or its antigen in blood and/or CSF is detected. In our
study we categorized patients as probable meningococcal meningitis if CSF
had polymorphs (irrespective of neck stiffness) and positive Gram stain or
rash (not just because of presentation during the outbreak).
Probable meningococcemia: A child presenting with
sudden onset fever with or without shock and either rash (petechial or
purpural) or positive Gram stain (of scrapings from rash).
Confirmed meningococcemia: A child with suspicion
of probable meningococcemia becomes confirmed if N. meningitides or
its antigen in blood and/or CSF is demonstrated.
Patients were treated with injection ceftriaxone as
first line therapy given for 7-10 days along with supportive care and
monitoring.
Results
A total of 100 children were admitted with maximum in
late winter and spring. 82% children were between 5-12 years of age, 5%
were <1 year and there were no neonates. The male: female ratio was 1.8:1.
Most cases were from the walled city (43) and east Delhi (25). There were
9 cases from central Delhi, 13 from south Delhi, 4 from north Delhi and 6
from Uttar Pradesh.
Table I shows clinical features at admission
and observed complications. 52% children had symptoms for <24 hours, 21%
for 24-48 hours, 26% for 2-5 days and 1% for >5 days. Meningococcal
meningitis and meningococcemia was diagnosed in 67 and 20 children,
respectively with a corresponding mortality of 4.5% (3/67) and 25% (5/20).
Thirteen children presented with both meningococcemia and meningitis; of
these 9 died (mortality 69%). Of 67 children with meningitis, 45 had
probable meningitis while 22 were confirmed.
Most patients stayed for 7-10 days (mean 8.99 days,
range 1-75 days). 17% children died. Almost all deaths occurred within or
shortly after 24 hours (mean duration 1.11 days). Mortality was 80% in
children <1 year and 13% in those aged 1-12 years. There was no
correlation of mortality with duration of symptoms or rash. However
mortality increased significantly with altered sensorium (31.7 % with
altered sensorium vs. 6.7% with normal sensorium, P=0.002)
or shock at presentation (53.8% with shock vs. 4% without shock,
P=0.001).
All the 26 positive cultures (13/98 blood cultures and
13/89 CSF cultures) had group A Neisseria meningitides. All
isolates were sensitive to penicillin/ampicillin (either of penicillin or
ampicillin was tested), ceftriaxone, chloromycetin, ciprofloxacin and
erythromycin; only one isolate each was resistant to ampicillin and
erythromycin. Isolates were also sporadically tested to some of other
antibiotics e.g., cefuroxime, netilmycin, amikacin, cefotaxime,
cotrimoxazole, meropenem, imipenem, amoxicillin and cloxacillin, and all
were reported sensitive.
Discussion
Meningococcal infection occurs worldwide with serogroup
A more prevalent in developing countries and serogroup B and C in
developed world(2). More than 80% of our children were above 5 years of
age . In endemic meningococcal meningitis from USA, maximum cases were
reported below 1-2 years of age(3). In epidemic outbreaks a shift to
higher age occurs(4). In an outbreak of group A meningococcal meningitis
in Sudan, 58% were above 5 years(5). Peak incidence was found in 10-14 yr
old children in an outbreak of group A meningococcal meningitis in
Ghana(6). Neonatal meningococcal meningitis is rare(7).
Mortality in our study was comparable to other
studies(3-5,8). In our study mortality was not affected by duration of
symptoms unlike Sudan outbreak, where it was higher in those presenting
within 24 hours(5). Other studies also reported significantly higher
mortality in patients presenting with shock or coma, as seen in our
study(5,8).
This was a retrospective study on a small number of
children during an outbreak, showing that early clinical suspicion, prompt
treatment and prophylaxis can be life saving. Rate of isolation of
meningococcus is not very high and antigen detection, Gram stain and
clinical diagnosis based on standard case definitions are useful. At
present Neisseria meningitides is sensitive to many antibiotics but
continued surveillance is necessary for development of resistance and more
prospective studies would be informative.
Contributors: UJ was involved in concept, acquision
and analysis of data, revising the draft critically and final approval of
the version to be published. VC was involved in data analysis and
interpretation and drafting the article. SK helped in acquision and
analysis of data.
Funding: None.
Competing interests: None stated.
What This Study Adds?
• During outbreak of group A meningococcal
infection in Delhi, all isolates were sensitive to ciprofloxacin,
penicillin/ampicillin (except one), ceftriaxone and chloramphenicol.
• Altered sensorium and shock at presentation significantly
increased the mortality.
|
References
1. Meningococcal disease, need to remain alert. CD
Alert. New Delhi: Directorate General Health Services, Govt of India;
2005.
2. Ahlawat S, Kumar R, Roy P, Verma S, Sharma BK.
Meningococcal meningitis outbreak control strategies. J Commun Dis 2000;
32: 264-274.
3. Kaplan SL, Schutze GE, Leake JA, Barson WJ, Halasa
NB, Byington CL, et al. Multicenter surveillance of invasive
meningococcal infections in children. Pediatrics 2006; 118: e979-984.
4. Deuren MV, Brandtzaeg P, Van der Meer JWM. Update on
meningococcal disease with emphasis on pathogenesis and clinical
management. Clin Microbiol Rev 2000; 13: 144-166.
5. Salih MA, Ahmed HS, Osman KA, Kamil I, Palmgren H,
HofvanderY, et al. Clinical features and complications of epidemic
group A meningococcal disease in Sudanese children. Ann Trop Pediatr 1990;
10: 231-238.
6. Belcher DW, Sherriff AC, Nimo KP, Chew GLN, Voros A,
Richardson WD, et al. Meningococcal meningitis in Northern Ghana:
epidemiology and control measures. Am J Trop Med Hyg 1977; 26: 748-755.
7. Chiu CH, Lin Ty, Yang PH, Hwang MS. Neonatal
meningococcal meningitis: report of cases. Zhonghua Min Guo Xiao Er Ke Yi
Xue Hui Za Zhi 1994; 35: 542-545.
8. Angyo IA, Okpeh ES. Clinical predictors of epidemic
outcome in meningococcal infection in Jos, Nigeria. East Afr Med J 1997;
74: 423-426.
|